NNC 45-0095
NNC 45-0095 is a chemical compound that belongs to the class of calcium channel blockers. It was developed by the Novo Nordisk company, hence the prefix "NNC" in its name. This compound is known for its selective inhibitory effect on the T-type calcium channel, which plays a crucial role in various physiological processes.
History[edit | edit source]
NNC 45-0095 was first synthesized and studied by the Danish pharmaceutical company Novo Nordisk. The company is known for its extensive research in the field of pharmacology and drug discovery, with a particular focus on diabetes and other metabolic disorders.
Pharmacology[edit | edit source]
NNC 45-0095 is a potent and selective inhibitor of the T-type calcium channel. Calcium channels are protein complexes that facilitate the movement of calcium ions across cell membranes. The T-type calcium channel is one of the several types of calcium channels found in the body. It is characterized by its transient opening and closing, hence the name "T-type" (transient type).
The inhibition of T-type calcium channels by NNC 45-0095 has been found to have potential therapeutic applications. For instance, it has been suggested that this compound could be used in the treatment of certain types of epilepsy, as well as in the management of pain and hypertension.
Clinical significance[edit | edit source]
The clinical significance of NNC 45-0095 lies in its potential therapeutic applications. Its ability to selectively inhibit T-type calcium channels makes it a promising candidate for the development of new drugs for the treatment of various disorders, including epilepsy, pain, and hypertension.
However, as of now, NNC 45-0095 is primarily used in research settings. Further studies are needed to fully understand its pharmacological properties and potential therapeutic benefits.
See also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
